LIN28A and cancer: Although previous reports on RBPs (LIN28A, YTHDFs, and Musashi) have shown that a single inhibition through shRNA, siRNA, or small molecules can suppress cancer stemness, these strategies have not yet been adopted in combination with existing chemotherapies to enhance the effects of chemotherapy.